Pandemic testing has become the new norm.
“We’ve gone from 1 million to 4.5 million tests per week in the U.S., but we’ll need to redouble our efforts to make it to 30 million tests per week and beyond in order to reopen communities and economies and keep them open,” says The Rockefeller Foundation.
While the news isn’t pleasant for many, it could create one of the most profitable opportunities for early investors.
In 2020, the testing market was worth approx. $84.4 billion. By 2022, according to Wells Fargo, the “testing economy” could be worth about $157 billion. That could create sizable opportunity for companies such as ScreenPro Security (CSE: SCRN), Laboratory Corp. of America Holdings (NYSE:LH), Abbott Laboratories (NYSE:ABT), Quest Diagnostics Inc. (NYSE:DGX), and Chembio Diagnostics Inc. (NASDAQ:CEMI).